company background image
HAEK logo

HAEMATO HMSE:HAEK Stock Report

Last Price

€14.25

Market Cap

€74.5m

7D

1.1%

1Y

n/a

Updated

31 Oct, 2024

Data

Company Financials +

HAEMATO AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for HAEMATO
Historical stock prices
Current Share Price€14.25
52 Week High€20.80
52 Week Low€13.90
Beta1.29
11 Month Change-8.06%
3 Month Change-12.58%
1 Year Changen/a
33 Year Changen/a
5 Year Changen/a
Change since IPO-31.49%

Recent News & Updates

Recent updates

Shareholder Returns

HAEKDE HealthcareDE Market
7D1.1%-3.0%-1.0%
1Yn/a26.3%16.1%

Return vs Industry: Insufficient data to determine how HAEK performed against the German Healthcare industry.

Return vs Market: Insufficient data to determine how HAEK performed against the German Market.

Price Volatility

Is HAEK's price volatile compared to industry and market?
HAEK volatility
HAEK Average Weekly Movement2.8%
Healthcare Industry Average Movement3.8%
Market Average Movement5.0%
10% most volatile stocks in DE Market10.9%
10% least volatile stocks in DE Market2.4%

Stable Share Price: HAEK has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: HAEK's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199376Patrick Brenskewww.haemato.ag

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cosmetics, as well as dietary supplements.

HAEMATO AG Fundamentals Summary

How do HAEMATO's earnings and revenue compare to its market cap?
HAEK fundamental statistics
Market cap€74.49m
Earnings (TTM)€9.61m
Revenue (TTM)€260.81m

7.8x

P/E Ratio

0.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HAEK income statement (TTM)
Revenue€260.81m
Cost of Revenue€241.08m
Gross Profit€19.73m
Other Expenses€10.12m
Earnings€9.61m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)1.84
Gross Margin7.56%
Net Profit Margin3.68%
Debt/Equity Ratio0.2%

How did HAEK perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

64%

Payout Ratio